Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation

@article{Schlienger2003EffectOS,
  title={Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation},
  author={R. Schlienger and C. R. Meier},
  journal={American Journal of Cardiovascular Drugs},
  year={2003},
  volume={3},
  pages={149-162}
}
  • R. Schlienger, C. R. Meier
  • Published 2003
  • Medicine
  • American Journal of Cardiovascular Drugs
    • In recent years a large body of evidence from several longitudinal studies has emerged suggesting that depression is an independent risk factor for cardiovascular disease (CVD) and that the association between depression and increased CVD risk is not merely due to negative mood-driven behavior related with depression. Even though the underlying mechanisms are not well understood, several hypotheses and explanations have been proposed such as increased activation of the hypothalamic-pituitary… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    41 Citations
    Background Citations
    14
    41 Citations
    Citation Type

    Citation Type

    Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction
    • 86
    Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
    • 61
    • PDF
    Fluoxetine and nortriptyline affect NTPDase and 5'-nucleotidase activities in rat blood serum.
    • 4
    The contribution of platelet studies to the understanding of disease mechanisms in complex and monogenetic neurological disorders
    • 18
    Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability
    • 33
    Results Population Characteristics and Platelet Aggregation Healthy Volunteers Enrolled in the Heredity and Phenotype Intervention (hapi) Heart Trial Were Selected for Metabolic Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability ; on Behalf of the Pharmacometab
      Venous thromboembolism and escitalopram.
      • 28
      5‐HYDROXYTRYPTAMINE IN THE CARDIOVASCULAR SYSTEM: FOCUS ON THE SEROTONIN TRANSPORTER (SERT)
      • W. Ni, S. Watts
      • Medicine, Biology
      • Clinical and experimental pharmacology & physiology
      • 2006
      • 148
      Degree of serotonin reuptake inhibition of antidepressants and ischemic risk
      • 6
      Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression
      • 53

      References

      SHOWING 1-10 OF 115 REFERENCES
      Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
      • 156
      Increased platelet aggregability in major depression?
      • 76
      Abnormal Platelet Aggregation Associated with Fluoxetine Therapy
      • 65
      Role of catecholamines in platelet function: pathophysiological and clinical significance
      • 159
      Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.
      • 98
      • PDF
      Platelets and coronary heart disease: potential psychophysiologic mechanisms.
      • 175
      Exaggerated platelet reactivity in major depression.
      • 522
      Clinical overview of serotonin reuptake inhibitors.
      • 163
      Serotonin and Fluoxetine Levels in Plasma and Platelets After Fluoxetine Treatment in Depressive Patients
      • 45
      Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
      • 227
      • PDF